**Core Concept**
Purine metabolism refers to the series of biochemical reactions involved in the synthesis and degradation of purine nucleotides, which are essential components of DNA and RNA. The human body produces purines through the de novo pathway and recycles them through the salvage pathway.

**Why the Correct Answer is Right**
The de novo purine synthesis pathway involves a series of enzyme-catalyzed reactions that convert amino acids, carbon dioxide, and ATP into inosine monophosphate (IMP), a precursor to purine nucleotides. This pathway is essential for producing purines during fetal development and in situations where the body requires rapid purine synthesis. Key enzymes involved in this pathway include phosphoribosyl pyrophosphate synthetase, PRPP, and adenylosuccinate synthetase.

**Why Each Wrong Option is Incorrect**
**Option A:** This option is incorrect as it does not describe a product of purine metabolism. Purine metabolism primarily involves the synthesis and degradation of purine nucleotides, not the production of pyrimidines.
**Option B:** This option is incorrect as it is a byproduct of uric acid metabolism, not purine metabolism. Uric acid is the final breakdown product of purine catabolism.
**Option C:** This option is incorrect as it is a product of pyrimidine metabolism, not purine metabolism. Pyrimidine metabolism involves the synthesis and degradation of pyrimidine nucleotides, such as cytosine and thymine.

**Clinical Pearl / High-Yield Fact**
In individuals with defects in purine metabolism, such as xanthinuria or gout, the body's inability to properly break down purines can lead to the accumulation of uric acid, resulting in increased risk of kidney stones and gouty arthritis.